Careers
Contact Us

Stories tagged hiv vaccine

Clinical Trial of HIV Vaccine Begins in United States and South Africa

Clinical Trial of HIV Vaccine Begins in United States and South Africa

News ReleasesJuly 13, 2023
Arrested Development:

Arrested Development:

Discontinuation of the MOSAICO Trial, its Legacy and Expectations for HIV Vaccine Research
Community CompassJuly 05, 2023
Opening Doors for TB and HIV Clinical Trials

Opening Doors for TB and HIV Clinical Trials

Community CompassJuly 05, 2023
HIV Vaccine Research: Community Perceptions Versus Reality

HIV Vaccine Research: Community Perceptions Versus Reality

Community CompassJuly 05, 2023
Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)

Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)

The HIV Vaccine Trials Network (HVTN), the NIH/NIAID Division of AIDS (DAIDS), and Janssen Vaccines and Prevention are pleased to welcome scientific study proposals involving specimens and/or study data from the Imbokodo (HVTN 705/VAC89220HPX2008) HIV vaccine clinical trial.
HVTN NewsFebruary 07, 2023
Where Are We Now and What’s Next?

Where Are We Now and What’s Next?

Mosaico Study Update
HVTN NewsJanuary 26, 2023
Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
News ReleasesJanuary 18, 2023
New Red Ribbon Registry

New Red Ribbon Registry

Community CompassJuly 12, 2022
Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Community CompassJuly 12, 2022
Increased support needed for a coordinated global HIV and COVID-19 response

Increased support needed for a coordinated global HIV and COVID-19 response

News ReleasesMarch 23, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant

Trial of innovative HIV vaccine using mRNA technology enrolls first participant

News ReleasesMarch 14, 2022
Mosaico Study Update

Mosaico Study Update

Community CompassDecember 01, 2021
Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

News ReleasesAugust 31, 2021
Reflections on communicating hope from the ground up in commemoration of World AIDS Day

Reflections on communicating hope from the ground up in commemoration of World AIDS Day

HVTN NewsDecember 01, 2020
Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

News ReleasesMarch 23, 2020
HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN NewsMarch 20, 2020
Experimental HIV vaccine regimen ineffective in preventing HIV

Experimental HIV vaccine regimen ineffective in preventing HIV

News ReleasesFebruary 03, 2020
HVTN study confirms correlates of risk associated with decrease in HIV transmission

HVTN study confirms correlates of risk associated with decrease in HIV transmission

News ReleasesOctober 31, 2019
HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

News ReleasesOctober 01, 2019
Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

News ReleasesSeptember 18, 2019

News on HVTN

Read MORE
A promising HIV vaccine candidate gets a little help
A promising HIV vaccine candidate gets a little help New strategy stirs a robust response from T cells tracked by McElrath lab May 24, 2023
Year in Pictures: 2022
Year in Pictures: 2022 A look back at the year through compelling images December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one?
Could a 100-year-old TB vaccine help scientists find a better one? Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for his lifetime achievements against infectious diseases October 21, 2022